Moreadith Randall

Chief Scientific OfficerSerina Therapeutics, Inc. (SER) · full profile →Form 4 · filed Dec 11, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$4K
Net Open-Market Flow
-$4K
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 10, 2025Grant(A)645$0.06$39645
Dec 10, 2025Sell(S)645$3.35$2K0
Dec 9, 2025Option exercise(M)600$0.06$36600
Dec 9, 2025Sell(S)600$3.31$2K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 10, 2025Option exercise(M)645$0370K
Dec 9, 2025Option exercise(M)600$0371K

Transaction Codes

A
Grant / award
S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001301120-25-000027) within minutes of acceptance. Every field above traces to the original document. Verify it directly: